Our mission is to enable immediate detection of treatment response to accelerate cancer research on emerging immunotherapies.

Lodestone’s biosensor technology provides localized signals of immune system activity to guide research on emerging immunotherapies during preclinical development

Non-invasive, longitudinal, real-time monitoring of signaling factors in the tumor microenvironment is a powerful new tool to help immunology researchers to fight cancer at its core.